CM
RIGL icon

Caption Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Caption Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,400
Closed -$558K – 1793
2022
Q2 		$558K Buy
+49,400
New +$992K 0.01% 1046
2022
Q1 		– Sell
-13,750
Closed -$364K – 1869
2021
Q4 		$364K Buy
13,750
+250
+2% +$7.54K ﹤0.01% 1324
2021
Q3 		$490K Sell
13,500
-8,750
-39% -$344K 0.01% 1201
2021
Q2 		$966K Buy
22,250
+19,750
+790% +$746K 0.01% 907
2021
Q1 		$86K Buy
+2,500
New +$99K ﹤0.01% 966
2020
Q4 		– Sell
-7,000
Closed -$168K – 1206
2020
Q3 		$168K Buy
+7,000
New +$172K ﹤0.01% 920

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Caption Management's RIGL Position: Q3 2022 in Review

Caption Management sold out of Rigel Pharmaceuticals (RIGL) in Q3 2022, closing a stake of 34,530 shares — an estimated $390K sold.

Caption Management first reported a position in RIGL in Q4 2018 and held it in 4 quarters. The position peaked at $390K in Q2 2022. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2022.

  • Caption Management reported no remaining Rigel Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Caption Management sold 34,530 Rigel Pharmaceuticals shares in Q3 2022, an estimated $390K.
  • Caption Management first reported a position in Rigel Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Caption Management's Rigel Pharmaceuticals position peaked at $390K in Q2 2022.
  • 138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2022.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.